Baudax Bio, Inc.
Nanoparticulate meloxicam formulations

Last updated:

Abstract:

The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.

Status:
Grant
Type:

Utility

Filling date:

25 Aug 2019

Issue date:

14 Jul 2020